Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy

RC581-951 Research Letter Specialties of internal medicine
DOI: 10.1182/bloodadvances.2024014518 Publication Date: 2024-11-20T20:32:10Z